Results 311 to 320 of about 791,952 (357)

Meta-analysis of Adjuvant Radiotherapy for Intracranial Atypical and Malignant Meningiomas

Skull Base, 2021
Ansley Unterberger, Thien Nguyen, Courtney Duong, Aditya M. Kondajji, Daniel P. Kulinich, I. Yang   +5 more
semanticscholar   +1 more source

Postoperative Adjuvant Radiotherapy – Standard of Care?

2008
Within 5 years following radical prostatectomy, between 15 and 60% of patients with pT3 prostate carcinomas show an increasing prostate-specific antigen (PSA) level as a sign of local and/or systemic tumor progression. Apart from a large number of retrospective investigations, results are available from 3 randomized studies.For pT3 prostate carcinomas,
Dirk, Bottke, Thomas, Wiegel
openaire   +2 more sources

Long-Term Costs of Adjuvant Radiotherapy

1982
Before discussing long-term costs it is worthwhile to define adjuvant radiotherapy. We cannot surely define as adjuvant the irradiation that follows a nonradical operation, because such treatment is compulsory and long-term costs are the price of recovery. We cannot talk about adjuvant treatment also after radical but limited surgery, such as a partial
F, Volterrani, D, Sigurtà
openaire   +2 more sources

Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients.

Ophthalmic Plastic and Reconstructive Surgery, 2018
PURPOSE To describe the clinical outcomes of eye-preserving surgery followed by adjuvant radiotherapy in patients with lacrimal gland carcinoma. METHODS Thirty-seven patients with lacrimal gland carcinoma who underwent eye-preserving surgery were ...
K. Woo, O. Sagiv, Jisang Han, S. Frank, Yoon-Duck Kim, B. Esmaeli   +5 more
semanticscholar   +1 more source

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.

The Lancet Oncology, 2020
A. Kneebone, C. Fraser-Browne, G. Duchesne, R. Fisher, M. Frydenberg, A. Herschtal, S. Williams, Chris Brown, W. Delprado, A. Haworth, D. Joseph, Jarad Martin, J. Matthews, J. Millar, M. Sidhom, N. Spry, Colin I Tang, S. Turner, K. Wiltshire, H. Woo, I. Davis, T. Lim, M. Pearse   +22 more
semanticscholar   +1 more source

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

The Lancet Oncology, 2009
R. Stupp, M. Hegi, W. Mason, M. J. van den Bent, M. Taphoorn, R. Janzer, S. Ludwin, A. Allgeier, B. Fisher, K. Bélanger, P. Hau, A. Brandes, J. Gijtenbeek, C. Marosi, C. Vecht, K. Mokhtari, P. Wesseling, S. Villà, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. Cairncross, R. Mirimanoff   +23 more
semanticscholar   +1 more source

Adjuvant surgery after radiotherapy.

Journal of the National Cancer Institute. Monographs, 1997
Investigators disagree about the role of adjuvant hysterectomy after irradiation of bulky stage IB cervical carcinomas, although the benefit of combined treatment has never been clearly demonstrated. Studies that have correlated outcome with initial tumor diameter suggest that central recurrences are rare after irradiation of tumors less than 5 cm in ...
openaire   +1 more source

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

[Adjuvant radiotherapy of breast carcinoma].

Praxis, 1995
Adjuvant postoperative radiotherapy for breast conserving treatment is well established. Contraindications against breast conservation are macroscopic tumor residues, multicentric disease, diffuse microcalcifications or inflammatory carcinoma because of the necessary radiation (dose) which exceeds the tolerance of the breast.
M H, Seegenschmiedt, R, Sauer, V, Strnad
openaire   +1 more source

Management of glioblastoma: State of the art and future directions

Ca-A Cancer Journal for Clinicians, 2020
Aaron Tan, David M Ashley, Giselle Lopez
exaly